Patent details
EP1853293 Title: THYMOSIN BETA 4 FOR TREATING MULTIPLE SCLEROSIS
Basic Information
- Publication number:
- EP1853293
- PCT Application Number:
- PCT/US/2006/001255
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP067183426
- PCT Publication Number:
- WO/2006/076588
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- THYMOSIN BETA 4 FOR TREATING MULTIPLE SCLEROSIS
- French Title of Invention:
- THYMOSINE BETA 4 POUR LE TRAITEMENT DE LA SCLÉROSE EN PLAQUES
- German Title of Invention:
- THYMOSIN BETA 4 ZUR BEHANDLUNG VON MULTIPLER SKLEROSE
- SPC Number:
Dates
- Filing date:
- 13/01/2006
- Grant date:
- 21/12/2016
- EP Publication Date:
- 21/12/2016
- PCT Publication Date:
- 20/07/2006
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 14/11/2007
- EP B1 Publication Date:
- 21/12/2016
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 13/01/2017
- Expiration date:
- 13/01/2026
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 13/01/2006
- Name:
- Regenerx Biopharmaceuticals Inc.
- Address:
- 3 Bethesda Metro Center, Suite 630, Bethesda, Maryland 20814, United States (US)
Inventor
1
- Name:
- FINKELSTEIN Jack, Jr.
- Address:
- United States (US)
2
- Name:
- GOLDSTEIN Allan L.
- Address:
- United States (US)
Priority
- Priority Number:
- 643307 P
- Priority Date:
- 13/01/2005
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 38/08;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|